Skip to main content

Table 3 Doses of different APs in different disorders at discharge (N = 603a)

From: Off-label use of antipsychotic medications in psychiatric inpatients in China: a national real-world survey

  Chlorpromazine equivalent Olanzapine Quetiapine Risperidone Aripiprazole Clozapine
Total Sample 231.56 ± 191.49 9.04 ± 5.80 185.13 ± 174.72 2.98 ± 1.71 9.13 ± 6.32 86.05 ± 117.15
MDD 199.06 ± 192.67 7.66 ±  5.62 180.08 ±  175.44 3.14 ± 1.57 10.33 ±  7.16 95.94 ± 164.72
AD 144.32 ± 144.67 6.97 ±  5.75 111.31 ±  121.38 5.83 ± 3.82 85 ±  99.62
DCR 336.22 ± 200.7 11.18 ± 5.79 266.43 ±  210.70 3.32 ± 1.49 16 ± 9.62 75 ±  35.36
OMD 285.78 ± 167.56 10.63 ± 5.49 232.35 ±  194.41 2.73 ±  1.42 6..5 ± 3.35 225
MDPS 214.82 ± 140.55 9.75 ± 5.19 208.09 ±  143.54 2.7 ± 1.06 7.5 ±  3.54 25
Dementia 138.02 ± 131.22 6.98 ±  5.53 103.33 ± 95 1.47 ± 1.76 10 12.5
SMD 206.56 ± 132.97 6.56 ± 3.99 200 ±  180.28 1
OCD 168.21 ± 75.64 5 250 ±  70.71 3 8.25 ± 4.42
Insomnia 150 ±  129.9 10 100
BEDO 284.50 ± 185.73 12.5 ±  3.54 333.33 ± 251.66 3.5 ± 0.7 7.5 ±  2.74 25
Other 308.65 ± 247 9.89 ± 6.52 247.22 ±  251.39 4.55 ± 1.95 6.88 ± 6.23 87.5 ±  53.03
  1. The data in the table was described with Mean ± Standard deviation
  2. aThere are 17 patients whose data of APs dose were not available
  3. APs antipsychotics, MDD major depression disorders, AD anxiety disorder, DCR dissociative (conversion) disorders, OMD organic mental disorders, MDPS mental disorders due to psychoactive substances, SMD somatoform disorders, OCD obsessive-compulsive disorder, BEDO behavioural and emotional disorders with onset usually occurring in childhood and adolescence